You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / SAKAR HEALTHCARE

SAKAR HEALTHCARE
Intrinsic Value | Fundamental Analysis

Returns | 1W : -2.9% , 1M : 15.3%,1Y : 240.7%
BOM :      NSE : SAKAR    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Jul 30,2021
Price(EOD): Rs. 180.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SAKAR HEALTHCARE -2.9% 15.3% 240.7%
SUN PHARMACEUTICAL INDUSTRIES 10% 14.6% 45.8%
DR REDDYS LABORATORIES -12.9% -13.1% 15.3%
DIVIS LABORATORIES -0.3% 11.3% 106.9%
CIPLA -3.2% -5.3% 33.1%
BIOCON -0.7% -4.4% -4.2%
AUROBINDO PHARMA -3.8% -5% 14.8%
LUPIN -5.5% -3.7% 29%
TORRENT PHARMACEUTICALS -0.3% 5.8% 32.6%


FUNDAMENTAL ANALYSIS OF SAKAR HEALTHCARE

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than SAKAR HEALTHCARE Plus/Pro


VALUATION OF SAKAR HEALTHCARE

 
Valuation Score
[As on : Jul 30,2021 ]

Ratio Standalone
P/E
P/B
P/S
28.02
P/E Calculated based on EPS of 6.43
[ Mar2020 - Standalone Results ]

3.32
P/B Calculated based on Book Value of 54.35
[ Mar2020 - Standalone Results ]

3.25
P/S Calculated based on Revenues of 94.74 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than SAKAR HEALTHCARE Plus/Pro


FAIR VALUE OF SAKAR HEALTHCARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
225%
263%

SHARE PRICE MOMENTUM OF SAKAR HEALTHCARE

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.21
0.16
0.31
0.23
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-19.08%
83.31%
-0.58%
-3.06%
18.74%
53.27%
-27.26%
-39.04%
QtrlyTrend
-2
Latest Qtr: Mar2021

SAKAR HEALTHCARE related INDICES

No BSE index found!
No NSE index found

FAQ [Frequently Asked Questions]


Is SAKAR HEALTHCARE good for long term investment?

As on 30-Jul-2021, the Fundamentals of SAKAR HEALTHCARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of SAKAR HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SAKAR HEALTHCARE UnderValued or OverValued?

As on 30-Jul-2021, SAKAR HEALTHCARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SAKAR HEALTHCARE ?

As on 30-Jul-2021, the Intrinsic Value of SAKAR HEALTHCARE is Rs. 52.54 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -10.95
Fair Value [Median EV / Sales Model] : Rs. 55.47
Fair Value [Median Price / Sales Model] : Rs. 49.62
Median Fair Value of SAKAR HEALTHCARE : Rs. 52.54

Is SAKAR HEALTHCARE trading at a Premium or Discount?

As on 30-Jul-2021, SAKAR HEALTHCARE is trading at a Premium of 243% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of SAKAR HEALTHCARE ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of LUPIN LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD

What are the Frequent Comparisons with SAKAR HEALTHCARE ?

Compare Analytics
SAKAR HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
SAKAR HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
SAKAR HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
SAKAR HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
SAKAR HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
SAKAR HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
SAKAR HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
SAKAR HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
SAKAR HEALTHCARE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of LUPIN LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z